JW (Cayman) Therapeutics Co. Ltd
HKEX:2126.HK
1.37 (HKD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||
| Current Assets: | ||||||||||
| Cash & Cash Equivalents
| 1,005.909 | 1,373.222 | 1,553.126 | 1,781.404 | 2,243.957 | 2,651.744 | 3,122.81 | 946.318 | 288.994 | 0 |
| Short Term Investments
| 5.534 | 0 | 5.544 | 35.427 | 0.695 | 0 | 0.863 | 1.975 | 0.087 | 0 |
| Cash and Short Term Investments
| 1,005.909 | 1,373.222 | 1,553.126 | 1,816.831 | 2,243.957 | 2,651.744 | 3,122.81 | 946.318 | 288.994 | 0 |
| Net Receivables
| 22.791 | 0 | 36.708 | 34.855 | 22.857 | 0 | 11.56 | 0 | 0 | 0 |
| Inventory
| 34.778 | 44.294 | 63.347 | 30.959 | 47.685 | 18.283 | 3.418 | 0 | 0 | 0 |
| Other Current Assets
| 4.006 | 29.401 | 14.276 | 35.81 | 3.638 | 55.998 | 1.027 | 7.837 | 3.34 | 0 |
| Total Current Assets
| 1,067.484 | 1,446.917 | 1,667.457 | 1,918.455 | 2,318.137 | 2,726.025 | 3,138.815 | 954.155 | 292.334 | 0 |
| Non-Current Assets: | ||||||||||
| Property, Plant & Equipment, Net
| 343.11 | 400.893 | 442.037 | 465.36 | 466.028 | 405.659 | 366.487 | 295.267 | 248.014 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 718.298 | 996.701 | 1,011.194 | 1,003.991 | 1,006.338 | 996.246 | 926.577 | 923.621 | 175.56 | 0 |
| Goodwill and Intangible Assets
| 718.298 | 996.701 | 1,011.194 | 1,003.991 | 1,006.338 | 996.246 | 926.577 | 923.621 | 175.56 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 17.205 | 16.923 | 13.267 | 5.687 | 21.934 | 60.224 | 49.238 | 45.16 | 32.006 | 0 |
| Total Non-Current Assets
| 1,078.613 | 1,414.517 | 1,466.499 | 1,475.039 | 1,494.3 | 1,462.128 | 1,342.302 | 1,264.047 | 455.58 | 0 |
| Total Assets
| 2,146.097 | 2,861.434 | 3,133.956 | 3,393.493 | 3,812.437 | 4,188.153 | 4,481.118 | 2,218.202 | 747.914 | 0 |
| Liabilities & Equity: | ||||||||||
| Current Liabilities: | ||||||||||
| Account Payables
| 3.269 | 7.363 | 8.537 | 6.325 | 3.138 | 13.925 | 1.069 | 6.739 | 7.701 | 0 |
| Short Term Debt
| 121.005 | 245.145 | 171.667 | 26.189 | 24.693 | 19.954 | 12.901 | 11.104 | 11.293 | 0 |
| Tax Payables
| 6.622 | 2.411 | 4.028 | 3.312 | 5.468 | 3.372 | 1.881 | 0.512 | 0.331 | 0 |
| Deferred Revenue
| 105.816 | 28.215 | 1.123 | 0.517 | 1.763 | 1.349 | 8.052 | 4.995 | 1.181 | 0 |
| Other Current Liabilities
| 34.379 | 95.302 | 167.66 | 160.785 | 213.714 | 202 | 259.028 | 196.378 | 117.207 | 0 |
| Total Current Liabilities
| 264.469 | 376.025 | 348.987 | 193.816 | 243.308 | 237.227 | 281.05 | 219.216 | 137.383 | 0 |
| Non-Current Liabilities: | ||||||||||
| Long Term Debt
| 197.79 | 133.774 | 103.853 | 104.324 | 116.21 | 117.183 | 118.564 | 2,999.165 | 1,645.764 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 42.509 | 37.868 | 45.34 | 38.96 | 14.378 | 15.072 | 13.283 | 18.864 | 0 |
| Total Non-Current Liabilities
| 197.79 | 176.282 | 141.721 | 149.664 | 155.17 | 131.561 | 133.636 | 3,012.448 | 1,664.628 | 0 |
| Total Liabilities
| 462.259 | 552.307 | 490.708 | 343.48 | 398.478 | 368.788 | 414.686 | 3,231.664 | 1,802.01 | 0 |
| Equity: | ||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.027 | 0.029 | 0.03 | 0.032 | 0.033 | 0.032 | 0.031 | 0.008 | 0.004 | 0 |
| Retained Earnings
| -4,965.334 | -4,938.57 | -4,712.518 | -4,431.39 | -4,099.411 | -3,520.975 | -3,140.613 | -1,791.432 | -1,101.897 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 6,649.145 | 687.595 | 528.625 | 353.602 | 75.068 | 99.703 | 65.846 | 45.191 | 2.365 | 0 |
| Other Total Stockholders Equity
| 0 | 6,560.073 | 6,827.111 | 7,127.77 | 7,438.27 | 7,240.605 | 7,141.168 | 732.772 | 45.432 | 0 |
| Total Shareholders Equity
| 1,683.838 | 2,309.127 | 2,643.248 | 3,050.013 | 3,413.959 | 3,819.365 | 4,066.432 | -1,013.462 | -1,054.096 | 0 |
| Total Equity
| 1,683.838 | 2,309.127 | 2,643.248 | 3,050.013 | 3,413.959 | 3,819.365 | 4,066.432 | -1,013.462 | -1,054.096 | 0 |
| Total Liabilities & Shareholders Equity
| 2,146.097 | 2,861.434 | 3,133.956 | 3,393.493 | 3,812.437 | 4,188.153 | 4,481.118 | 2,218.202 | 747.914 | 0 |